Health Benefits of Nutraceutical Supplementation in Older Adults. (NCT07534878) | Clinical Trial Compass
CompletedPhase 4
Health Benefits of Nutraceutical Supplementation in Older Adults.
India23 participantsStarted 2025-12-24
Plain-language summary
This study examines a multi-ingredient nutraceutical designed to support several areas of health in older adults, including muscle strength, cognitive function, immune response, and inflammation. Unlike single-drug treatments, the ingredients work together through complementary mechanisms across different biological systems. Since this combined approach has not been clinically tested before, the trial will provide early evidence on functional outcomes and biomarker changes. The main goal is to measure improvements in muscle performance, while secondary goals include evaluating effects on cognition, immunity, inflammation, safety, and tolerability in older adults.
Who can participate
Age range
50 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Generally healthy participants with a life expectancy ≥ 5 years
* Male and female participants aged 50 to 80 years
* Body Mass Index (BMI) between 25 to 35 kg/m²
* Health not severely compromised (no life-threatening illness or disability)
Participants with:
* Intrinsic Capacity score showing mild to moderate decline
* Short Physical Performance Battery (SPPB) score between 9 to 11
* Montreal Cognitive Assessment (MoCA) score \> 20 and ≤ 25
* Participants with or without comorbidities; if present, must be on a stable treatment regimen (same drug and dose) for at least 12 weeks prior to screening
* Able and willing to:
* Provide written informed consent
* Comply with study protocol requirements
* Read and write in English
Exclusion Criteria:
* Severe or uncontrolled chronic diseases (e.g., severe osteoarthritis, advanced cardiovascular disease, kidney failure, uncontrolled diabetes, severe COPD, terminal cancer)
* Physical disability requiring a walker or wheelchair
* Diagnosed dementia or cognitive impairment preventing protocol compliance
* Acute infection or illness within 3 months prior to enrollment
* Unstable medical conditions (e.g., recent myocardial infarction, unstable angina, uncontrolled hypertension)
* Major surgery within the past 6 months or planned during the study
* Severe psychiatric disorders unless well controlled
* Substance abuse within the past 6 months
* Participation in another clinical trial within the last 6 months
* Known …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.